AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Sub (Q43668344)
Jump to navigation
Jump to search
scientific article published on 24 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Sub |
scientific article published on 24 July 2013 |
Statements
AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial (English)
Nihar R Desai
Payal Kohli
Michelle L O'Donoghue
Ransi Somaratne
Jing Zhou
Elaine B Hoffman
Fannie Huang
William J Rogers
Scott M Wasserman
Robert Scott
Marc S Sabatine